Latest Monoclonal antibodies Stories
New cutting-edge report “Global Cancer Monoclonal Antibodies Market & Pipeline Insight” worked out by Kuick Research is now available at MarketPublishers.com. London,
Physicians Indicate that Switching of Currently Treated Patients to Biosimilar Infliximab Is Likely to be Limited, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
-- Polyarticular juvenile idiopathic arthritis (JIA) occurs in approximately 25 percent of all JIA patients NORTH CHICAGO, Ill., Oct.
AbGenomics raised new fund for advancing its mid-stage clinical trials LOS ALTOS, Calif., Oct.
SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
The Firm is evaluating legal claims on behalf of individuals who allegedly suffered serious Xolair side effects, including heart attacks, mini-strokes, pulmonary hypertension, and blood clots
Featured Presentations Highlight Data From Approved and Investigational Agents Across Amgen's Dermatology Portfolio THOUSAND OAKS, Calif., Oct.
On September 26, the FDA issued a safety communication on potential risks of cardiovascular and cerebrovascular serious adverse events to Xolair's (omalizumab) drug label.
SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- Lpath, Inc.
- Growing in low tufty patches.
More Images (1 images) »